Orioled Hub and its partner pharmaceutical factory in Vietnam have recently undergone two comprehensive EU-GMP inspections conducted over a week from April 28 to May 5, 2023. The results of these inspections were a resounding success, and both companies have come out with flying colors.
For those needing to become more familiar with the term, EU-GMP stands for European Union Good Manufacturing Practice. Pharmaceutical companies must adhere to a set of quality standards to ensure that their products are safe, effective, and of high quality. Compliance with EU-GMP regulations is essential for any pharmaceutical company looking to market its products in the European Union.
Orioled Hub and its partner pharmaceutical factory in Vietnam could pass not one but two comprehensive EU-GMP inspections in the same week is a testament to their commitment to quality and dedication to producing safe and effective pharmaceutical products. It also indicates that both companies have established the necessary quality systems and processes to meet these stringent standards.
As a result of this success, Orioled Hub and its partner pharmaceutical factory are now well-positioned to expand their operations and bring their products to new markets. With their proven track record of quality and compliance with EU-GMP regulations, these companies are sure to be trusted and reliable partners for pharmaceutical companies worldwide. Congratulations to Orioled Hub and its partner pharmaceutical factory in Vietnam on this impressive achievement.
